Amplia Therapeutics Ltd (INNMF) Stock Price & News

All values in AUD	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	1.32M	1.32M	1.08M	1.08M
Cost of goods sold	79.04K	79.04K	113.74K	113.74K
Cost of revenue	79.04K	79.04K	113.74K	113.74K
Research and development expenses	2.50M	2.50M	2.04M	2.04M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	879.98K	879.98K	867.44K	867.44K
Operating expense	3.42M	3.42M	2.97M	2.97M
Total operating expenses	3.50M	3.50M	3.09M	3.09M
Operating income	-2.19M	-2.19M	-2.01M	-2.01M
Other non operating income	-	-	-	-
EBT including unusual items	-2.09M	-2.09M	-1.77M	-1.77M
EBT excluding unusual items	-2.09M	-2.09M	-1.77M	-1.77M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-2.09M	-2.09M	-1.77M	-1.77M
Net profit margin	-158.77%	-158.77%	-163.40%	-163.40%
Earnings per share	-	-	-	-
Interest and investment income	102.26K	102.26K	247.29K	247.29K
Interest expense	-2.30K	-2.30K	-6.38K	-6.38K
Net interest expenses	99.96K	99.96K	240.90K	240.90K
Depreciation and amortization charges	18.15K	18.15K	27.92K	27.92K
EBITDA	-2.17M	-2.17M	-2.00M	-2.00M
Gain or loss from assets sale	-	-	-	-

Finance